期刊文献+

两种不同方法输注美罗培南治疗重症感染患者的效果比较 被引量:15

Effects of 2 different infusion methods of meropenem on severe infection patients
下载PDF
导出
摘要 目的比较两种不同方法输注美罗培南治疗重症感染患者的效果。方法选取2015年1月1日至2016年12月31日入住四川省肿瘤医院重症监护病房(ICU)接受美罗培南治疗的重症感染患者53例为研究对象。采用随机数字表法将患者分为观察组(28例)和对照组(25例)。观察组采用优化两步输注法治疗,对照组采用常规间歇输注法治疗。观察2组患者的临床疗效[包括美罗培南治疗疗程、气管插管患者呼吸机通气时间、ICU治疗天数、总住院天数及医院内死亡率,治疗72 h后血清降钙素原、外周血白细胞计数(WBC)、C反应蛋白(CRP)水平]。结果 2组治疗疗程差异无统计学意义(P>0.05)。观察组中气管插管患者呼吸机通气时间、ICU治疗天数及总住院天数均短于对照组[(5±3)d比(9±5)d、(6±4)d比(10±6)d、(22±14)d比(31±15)d],差异均有统计学意义(均P<0.05)。观察组医院内死亡率低于对照组[14.3%(4/28)比32.0%(8/25)],但差异无统计学意义(P>0.05)。2组治疗72 h后降钙素原、WBC及CRP均低于治疗前,且观察组降钙素原及WBC低于对照组(均P<0.05)。结论优化两步输注法与传统的间歇输注法相比,能明显缩短气管插管患者呼吸机通气时间、ICU治疗天数及总住院天数,同时在改善治疗72 h后的降钙素原及WBC 2个感染指标方面更具优势。 Objective To compare the effects of 2 different infusion methods of meropenem 9n severe infection patients. Methods Fifty-three patients with severe infection who were treated by meropenem in Intensive Care Unit, Sichuan Cancer Hospital from January 1, 2015 to December 31, 2016 were randomly divided into observation group( 28 cases) and control group (25 cases). The observation group was treated by modified two-step infusion of meropenem; the control group was treated by routine intermittent infusion of meropenem. Therapeutic course of meropenem, mechanical ventilation time, ICU stay time, total hospital stay time and in-hospital mortality rate were recorded. Levels of serum procalcitonin (PCT), peripheral blood white blood cell count (WBC) and C-reactive protein(CRP) were tested before and 72 h after treatment. Results Therapeutic course showed no significant difference between groups ( P 〉 0.05 ). Mechanical ventilation time, ICU stay time and total hospital stay time in observation group were significantly shorter than those in control group [ (5 ± 3 )d vs (9±5 )d, (6± 4 ) d vs ( 10 ± 6 ) d, ( 22± 14 ) d vs ( 31 ± 15 ) d ] ( P 〈 0.05 ). In-hospital mortality rate in observation group was lower than that in control group[ 14. 3% (4/28) vs 32. 0% ( 8/25 ) ] ( P 〉 0.05 ). After 72 h treatment, PCT, WBC and CRP were significantly lower than those before treatment in both groups; PCT, WBC and CRP in observation group were significantly lower than those control group ( P 〈 0. 05 ). Conclusion Proper use of meropenem can significantly shorten mechanical ventilation time, ICU stay time, total hospital stay time and reduce infection.
作者 马雪 赵丽丽 越佩 李懿 杨勇 Ma Xue;Zhao Lili;Zhao Pei;Li Yi;Yang Yong(Department of Pharmacy, Sichuan Cancer Hospital & Institute, Medical College, University of Electronic Science and Technology of China, Chengdu 610054, China;Intensive Care Unit, Sichuan Cancer Hospital & Institute, Chengdu 610054, China;Department of Pharmacy, Affiliated Hospital of University of Electronic Science and Technology of China, Sichuan Provincial People's Hospital, Medical College, University of Electronic Science and Technology of China, Chengdu 610072, China)
出处 《中国医药》 2018年第4期594-597,共4页 China Medicine
关键词 重症感染 美罗培南 两步输注法 Severe infection Meropenem Two-step infusion
  • 相关文献

参考文献7

二级参考文献84

  • 1景炳文.乌司他丁在急危重症临床应用的进展[J].中国危重病急救医学,2006,18(2):117-120. 被引量:127
  • 2Wyeth Lederle SPA.Tazocin 注射用哌拉西林钠他唑巴坦钠)说明书.Catania,Italy;Wyeth Lederle SPA,2007.
  • 3MacArthur RD, Miller M, Albertson T, et al. Adequacy of early empiric antibiotic treatment and survival in severe sep- sis~ experience from the MONARCS trial [J]. Clin Infect Dis,2004,38(2) :284-288.
  • 4Drusano GL. Antimicrobial pharmacodynamics: critical inter- actions of "bug and drug' [J]. Nat Rev Microbiol 2004,2 (4) :289-300.
  • 5McKinnon PS, Paladino JA, Schentag JJ. Evaluation of area under the inhibitory curve (AUIC) and time above the mini mum inhibitory concentration (T> MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial in feetions[J]. Int J Antimicrob Agents, 2008,31 (4): 345-351.
  • 6Kim A, Sutherland CA, Kuti JL, et al. Optimal dosing of piperacillin-tazobaetam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion? [J]. Pharmacotherapy, 2007,27 (11 ) : 1490-1497.
  • 7Turnidge JD. The pharmacodynamics of β-lactams[J]. Clin Infect Dis, 1998,27 (1) : 10-22.
  • 8Eguchi K, Kanazawa K, Shimizudani T, et al. Experimental verification of the efficacy of optimized two-step infusion ther apy with meropenem using an in vitro pharmacodynamic mod- el and Monte Carlo simulation[J]. J Infect Chemother, 2010, 16(1) :1-9.
  • 9Sun HK, Kuti JL, Nicolau DP. Pharmacodynamics of antimi crobials for the empirical treatment of nosocomial pneumonia a report from the OPTAMA Program[J]. Crit Care Med 2005,33(10), 2222-2227.
  • 10Chu YZ, Tian SF, Chen BY, et al. Pharmacokinetie-pharma codynamic profiling of four antimicrobials against Gram-nega rive bacteria collected from Shenyang, China[J]. BMC Infect Disc, 2010, 10:171.

共引文献72

同被引文献126

引证文献15

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部